Anti-ADAMTS-18 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the metalloproteinase domain of human ADAMTS-18, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Dog
UniProt
Q8TE60
Size
100ug
Cat. #
RP2ADAMTS18

In stock

SKU
RP-ADAMTS18

Options

As low as: $130.00

Target Overview

ADAMTS-18 (a disintegrin and metalloproteinase with thrombospondin motifs 18; EC 3.4.24.-; UniProt Q8TE60) is a secreted metalloproteinase of the ADAMTS family localized to the extracellular matrix. The 1,221-amino acid enzyme contains an N-terminal metalloproteinase domain, a disintegrin-like domain, and multiple thrombospondin type-1 repeats characteristic of extracellular proteases that remodel matrix substrates. ADAMTS-18 cleaves fibronectin and negatively regulates its fibrillogenesis, a function documented by Barbiera et al. (2025) in studies of matrix assembly. Expression is detected in multiple tissues, and loss-of-function variants have been associated with hereditary conditions including microcornea, myopic chorioretinal atrophy, and telecanthus (MMAT syndrome). Recent work has implicated ADAMTS-18 in endometrial receptivity, stroke outcome prediction, and endometrial cancer pathogenesis, though the molecular mechanisms remain under investigation. Researchers studying extracellular matrix dynamics, fibronectin biology, and disease-associated proteinase activity rely on validated antibodies to detect ADAMTS-18 in lysates and tissue sections.

Background

ADAMTS-18 belongs to the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) superfamily of zinc-dependent proteases that regulate extracellular matrix composition, cell adhesion, and tissue remodeling. The enzyme processes fibronectin by proteolytic cleavage, thereby inhibiting the formation of fibronectin fibrils in the matrix, a finding that positions ADAMTS-18 as a negative regulator of fibrillogenesis. This activity distinguishes it from fibronectin-promoting factors and suggests a role in modulating matrix assembly during development, wound healing, or pathological remodeling. Loss-of-function mutations in the ADAMTS18 gene cause autosomal recessive microcornea, myopic chorioretinal atrophy, and telecanthus syndrome, underscoring the protease's importance in ocular and craniofacial development. Recent publications have expanded the scope of ADAMTS-18 research beyond developmental syndromes. Li et al. (2026) reported altered expression of ADAMTS18 in endometrial cancer and explored its mechanistic contribution to tumor behavior, though the directionality and functional consequences require further study. Cui et al. (2026) found that serum ADAMTS-18 levels measured at hospital admission correlate with three-month functional outcomes in acute ischemic stroke patients, suggesting potential utility as a prognostic biomarker. Nguyen et al. (2025) identified ADAMTS18 among genes modulated by human platelet lysate in the context of endometrial receptivity, linking the protease to reproductive physiology. These findings reflect growing interest in ADAMTS-18 beyond its established role in matrix biology. Triple Point Biologics offers rabbit polyclonal antibodies raised against the metalloproteinase domain of human ADAMTS-18, validated for Western blot. Two product configurations are available to meet differing experimental needs. Reactivity has been validated in human samples and is predicted in mouse, rat, dog, and non-human primate based on sequence homology. These reagents support investigations of ADAMTS-18 expression, localization, and substrate processing in development, disease, and extracellular matrix research.

References

  1. Barbiera M et al (2025) A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) cleaves fibronectin and negatively regulates its fibrillogenesis. J Biol Chem. PubMed · DOI
  2. Li X et al (2026) The expression and mechanism of action of ADAMTS18 in endometrial cancer. J Mol Histol. PubMed · DOI
  3. Cui T et al (2026) Serum ADAMTS18 Levels at Admission Are Associated With 3-Month Functional Outcome After Acute Ischemic Stroke. J Atheroscler Thromb. PubMed · DOI
  4. Nguyen TTN et al (2025) Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity. Hum Reprod. PubMed · DOI
  5. Aghasipour M et al (2025) Concurrent inheritance of achromatopsia and MMAT syndrome in a pedigree: Genetic and clinical insights. Eur J Med Genet. PubMed · DOI

Additional Specifications

Size 100 µg
Gene Symbol ADAMTS18
UniProt ID Q8TE60
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Dog
Pack Size 100ug
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 293-498.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 48-284.
Alternate Names ADAMTS-18, ADAM-TS 18, ADAM-TS18, A disintegrin and metalloproteinase with thrombospondin motifs 18, EC 3.4.24.-

Frequently Asked Questions

What molecular weight should I expect for ADAMTS-18 on Western blot?

Full-length ADAMTS-18 has a predicted molecular weight of approximately 135 kDa based on its 1,221-amino acid sequence. However, the mature secreted form runs closer to 130 kDa after signal peptide cleavage. You may observe additional bands representing proteolytically processed fragments, particularly in conditioned media samples, since ADAMTS-18 undergoes autocatalytic or exogenous cleavage in the extracellular space. If working with intracellular lysates, expect lower abundance compared to secreted fractions. Running a positive control from tissue or cells known to express ADAMTS-18 (e.g., ocular tissue lysates) will help confirm the expected pattern.

Is this ADAMTS-18 antibody validated in mouse and rat samples?

The antibody is validated in human samples and shows predicted cross-reactivity with mouse, rat, dog, and non-human primate based on epitope sequence homology. We have not independently confirmed detection in rodent lysates. Human and mouse ADAMTS-18 share approximately 80–85% sequence identity in conserved domains, so cross-reactivity is likely but band intensity may differ. If working with mouse or rat, start at the recommended 1:1000 dilution and be prepared to optimize. Include a human positive control on the same blot to verify antibody performance before troubleshooting species-specific detection issues.

What starting dilution should I use for Western blot with this antibody?

Start at 1:1000 dilution for Western blot in 5% non-fat milk or BSA in TBS-T. ADAMTS-18 is a secreted extracellular matrix protein, so signal intensity depends heavily on sample type. Conditioned media from cultured cells typically yields stronger signal than whole-cell lysates. If background is high at 1:1000, increase to 1:2000 or switch blocking agent. For very low-abundance samples or if detecting endogenous protein in primary tissue, you may need to concentrate your sample or test 1:500. Overnight incubation at 4°C often improves sensitivity compared to one hour at room temperature for this target.

Can I use this antibody for immunofluorescence on fixed cells?

Yes, Triple Point Biologics antibodies are validated for immunofluorescence applications. Because ADAMTS-18 is secreted and associates with the extracellular matrix, you will see predominantly extracellular or pericellular staining rather than intracellular localization in most cell types. Use methanol or paraformaldehyde fixation; permeabilization is less critical since the target is extracellular. Start with a 1:100–1:200 dilution and include cells cultured in serum-free media for 24–48 hours to enrich secreted ADAMTS-18 in the matrix. A no-primary-antibody control is essential to distinguish specific ECM staining from non-specific matrix binding.

What is the best sample type for detecting endogenous ADAMTS-18?

Conditioned serum-free media from cultured cells or tissue lysates enriched for extracellular matrix proteins yield the strongest signal. ADAMTS-18 is secreted, so whole-cell lysates contain primarily intracellular precursor and lower total abundance. If using cultured cells, switch to serum-free medium for 24–48 hours before harvest to reduce serum protein interference and enrich secreted proteinases. For tissues, ocular tissues (cornea, retina) and cartilage show relatively high endogenous expression. Concentrate conditioned media by ultrafiltration (10 kDa cutoff) or TCA precipitation if initial signal is weak. Avoid freeze-thaw cycles, as ADAMTS-18 activity and epitope integrity may decline.

Does ADAMTS-18 have splice isoforms I should know about?

ADAMTS-18 has limited documented splice variation compared to some other ADAMTS family members. The major transcript encodes the full 1,221-amino acid protein. Shorter variants have been reported in transcript databases but are not well characterized at the protein level. On Western blot, multiple bands most often reflect proteolytic processing rather than isoforms, since ADAMTS-18 is subject to cleavage in the extracellular space. If you observe multiple bands, consider whether they represent N-terminal fragments retaining the metalloproteinase domain or C-terminal fragments with thrombospondin repeats. Epitope mapping information for this antibody can help predict which fragments will be detected.

What positive and negative controls should I use for ADAMTS-18 Western blot?

A validated positive control is conditioned medium from HEK293 or other cells transfected with ADAMTS-18 expression vector, or lysate from human tissue known to express the protein (ocular tissues, certain carcinoma lines). Negative controls include lysate from cells with confirmed low or absent ADAMTS-18 expression, or the same sample pre-incubated with blocking peptide if available. Because ADAMTS-18 is secreted, side-by-side comparison of cell lysate versus conditioned medium from the same culture provides an internal control showing enrichment in the secreted fraction. Omitting primary antibody confirms specificity of the secondary detection system.

How should I store this antibody and how long is it stable?

Store at -20°C as supplied. Rabbit polyclonal antibodies in glycerol-containing buffer are stable for at least 12 months at -20°C. Avoid repeated freeze-thaw cycles; aliquot into single-use volumes if you will use the antibody infrequently. For short-term use (up to one month), you may store a working aliquot at 4°C with 0.02–0.05% sodium azide as preservative. Do not store diluted antibody in blocking buffer for more than one week, as carrier proteins can degrade and background may increase. If you observe decreased signal or increased background over time, prepare a fresh aliquot from the -20°C stock.

Validation imagery coming soon

Western blot validation figures for RP-ADAMTS18 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • ADAMTS-18
  • ADAM-TS 18
  • ADAM-TS18
  • A disintegrin and metalloproteinase with thrombospondin motifs 18
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →